Judging By the TweetNot much cryptic in the tweet as it certainly appearsTHRM isn't banking on HC approval anytime soon. While that's disappointing it's great to know they are forging ahead. In the meantime the opportunities look far more promising in terms of timing and potential revenues by thinking outside of Canada.
They have now been "patiently" waiting since February 26th for HC approval just to carry out the testing. Sorry, but there is no excuse for that ....especially as the current covid situation evolves here. Re-testing of AcuVid is likely already in the works in Brazil and clearly THRM is looking toward putting together a "resume" of testing results to move toward CE, FDA and EUA approval.
I thought that with the same 9 rapid, antigen point of care tests under review for weeks that HC would be moving much more quickly. Glad to see Rob and team are still modifying and changing the direction as required. Shouldn't be much longer to wait.
Looking forward to the next few weeks,
GLTE!!!